Drug Profile
Research programme: cognitive disorders therapy - Dart NeuroScience
Alternative Names: CREB activators - Dart NeuroScience; Multiple Novel targets- Dart NeuroSceince; Novel programs - Dart NeuroScienceLatest Information Update: 26 Dec 2022
Price :
$50
*
At a glance
- Originator Helicon Therapeutics
- Developer Dart NeuroScience
- Class Nootropics; Small molecules
- Mechanism of Action Cyclic AMP response element-binding protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cognition disorders
- Discontinued Memory disorders
Most Recent Events
- 26 Dec 2022 Early research is ongoing for Cognition disorders (Dart Neurosciences pipeline, December 2022) (http://dartneuroscience.com/DrugPrograms.php)
- 29 Aug 2019 Early research in Cognition disorders in USA (unspecified route) before August 2019 (Dart NeuroScience pipeline, August 2019)
- 29 Jan 2019 Discontinued - Preclinical for Memory disorders in USA (unspecified route) before August 2019 (Dart NeuroScience pipeline, August 2019)